Glazenburg et al., 1995 - Google Patents
Construction and properties of pseudorabies virus recombinants with altered control of immediate-early gene expressionGlazenburg et al., 1995
View PDF- Document ID
- 11354216923195653643
- Author
- Glazenburg K
- Peeters B
- Pol J
- Gielkens A
- Moormann R
- Publication year
- Publication venue
- Journal of virology
External Links
Snippet
To investigate how altered control of expression of the essential immediate-early (IE) gene of pseudorabies virus influences virus replication and virulence, we replaced the IE promoter with the tissue-specific promoters of the bovine cytokeratin IV gene (CKIV), the …
- 230000014509 gene expression 0 title abstract description 76
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
- C12N2710/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5905040A (en) | Parvovirus empty capsids | |
| Holland et al. | Physical mapping of the mutation in an antigenic variant of herpes simplex virus type 1 by use of an immunoreactive plaque assay | |
| Pensiero et al. | Expression of the Hantaan virus M genome segment by using a vaccinia virus recombinant | |
| JP2703538B2 (en) | Pseudorabies virus mutants, vaccines containing them, methods for their production and use | |
| EP0573614A1 (en) | Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof | |
| EP0162738A1 (en) | Production of pseudorabies virus subunit vaccines | |
| WO1987001287A1 (en) | Pseudorabies virus deletion mutants and vaccines containing same | |
| EP0101655B1 (en) | Production of herpes simplex viral proteins | |
| JPH05168473A (en) | Novel recombination body of herpes virus. vaccine based on the body. manufacture thereof. gene. vector and plasmid used therefor | |
| US7060282B1 (en) | Attenuated equine herpesvirus | |
| JP2003505103A (en) | Recombinant HSV-1 and live virus vaccine | |
| WO1984002847A1 (en) | Methods and materials for development of parvovirus vaccine | |
| Glazenburg et al. | Construction and properties of pseudorabies virus recombinants with altered control of immediate-early gene expression | |
| EP0769056B1 (en) | NON-SPLICING VARIANTS OF gp350/220 | |
| KR100224331B1 (en) | Herpes varicella zoster virus and its manufacturing method | |
| DK175072B1 (en) | Recombinant DNA molecule, host cell transformed therewith, method for producing a polypeptide using the recombinant DNA molecule, and diagnostic kit comprising such polypeptide | |
| US20040185056A1 (en) | Vaccines containing bovine herpesvirus 1 attenuated by mutation in latency-related gene | |
| WO1990001546A1 (en) | Equine herpesvirus-1 vaccine | |
| JP2905483B2 (en) | Attenuated herpes virus and herpes virus containing exogenous DNA | |
| JPH08294392A (en) | Dna arrangement for coding simple herpesvirus protein | |
| KR101111998B1 (en) | gM-Negative EHV-mutants without heterologous elements | |
| EP0668355A1 (en) | Vaccine for the protection of horses against equine herpesvirus infection | |
| JPH09505726A (en) | Recombinant infectious laryngotracheitis virus and their use | |
| CN114657154A (en) | Preparation method and application of attenuated strain of contagious ecthyma virus | |
| Kirisawa et al. | Isolation of equine herpesvirus-1 lacking glycoprotein C from a dead neonatal foal in Japan |